Thrombospondin-1-deficient mice are not protected from bleomycin-induced pulmonary fibrosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 44, Issue 4, 2011, Pages 556-561

  Ezzie, Michael E ^a   Piper, Melissa G ^a   Montague, Christine ^a   Newland, Christie A ^a   Opalek, Judy M ^a   Baran, Chris ^a   Ali, Naeem ^a   Brigstock, David ^b   Lawler, Jack ^c   Marsh, Clay B ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Bleomycin; Pulmonary fibrosis; TGf ; TSP 1

Indexed keywords

BLEOMYCIN; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE PREDISPOSITION; HOMOGENATE; INFLAMMATION; KNOCKOUT MOUSE; LUNG FIBROSIS; LYMPHOCYTE COUNT; MACROPHAGE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; BLEOMYCIN; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PNEUMONIA; PULMONARY FIBROSIS; RNA, MESSENGER; SMAD2 PROTEIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

MURINAE; MUS;

EID: 79953766252     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2009-0019OC     Document Type: Article

References (39)

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
2. Crystal RG, Bitterman PB, Mossman B, Schwarz MI, Sheppard D, Almasy L, Chapman HA, Friedman SL, King TE Jr, Leinwand LA, et al. Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 2002;166:236-246. (Pubitemid 34765460)
3. Bonniaud P, Martin G, Margetts PJ, Ask K, Robertson J, Gauldie J, Kolb M. Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" BALB/c mouse lungs. Am J Respir Cell Mol Biol 2004;31:510-516.
4. Lasky JA, Ortiz LA, Tonthat B, Hoyle GW, Corti M, Athas G, Lungarella G, Brody A, Friedman M. Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. Am J Physiol 1998;275:L365-L371.
5. Sheppard D. Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proc Am Thorac Soc 2006;3:413-417. (Pubitemid 44033355)
6. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000;342:1350-1358. (Pubitemid 30408720)
7. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998;93:1159-1170. (Pubitemid 28307421)
8. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, et al. The integrin alpha V beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999;96:319-328. (Pubitemid 29077586)
9. Yang Z, Mu Z, Dabovic B, Jurukovski V, Yu D, Sung J, Xiong X, Munger JS. Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice. J Cell Biol 2007;176:787-793. (Pubitemid 46425539)
10. Chen H, Herndon ME, Lawler J. The cell biology of thrombospondin-1. Matrix Biol 2000;19:597-614.
11. Agah A, Kyriakides TR, Lawler J, Bornstein P. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am J Pathol 2002;161:831-839. (Pubitemid 34988370)
12. Friedl P, Vischer P, Freyberg MA. The role of thrombospondin-1 in apoptosis. Cell Mol Life Sci 2002;59:1347-1357.
13. Adams JC. Thrombospondin-1. Int J Biochem Cell Biol 1997;29:861-865.
14. Silverstein RL. The face of TSR revealed: an extracellular signaling domain is exposed. J Cell Biol 2002;159:203-206.
15. Armstrong LC, Bornstein P. Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biol 2003;22:63-71. (Pubitemid 36444508)
16. Bouma-ter Steege JC, Mayo KH, Griffioen AW. Angiostatic proteins and peptides. Crit Rev Eukaryot Gene Expr 2001;11:319-334.
17. Carpizo D, Iruela-Arispe ML. Endogenous regulators of angiogenesis: emphasis on proteins with thrombospondin-Type I motifs. Cancer Metastasis Rev 2000;19:159-165. (Pubitemid 32004705)
18. Detmar M. Tumor angiogenesis. J Investig Dermatol Symp Proc 2000;5:20-23. (Pubitemid 32044085)
19. Lawler J. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med 2002;6:1-12. (Pubitemid 44133979)
20. Lawler J. The functions of thrombospondin-1 and -2. Curr Opin Cell Biol 2000;12:634-640.
21. Moodley Y, Rigby P, Bundell C, Bunt S, Hayashi H, Misso N, McAnulty R, Laurent G, Scaffidi A, Thompson P, et al. Macrophage recognition and phagocytosis of apoptotic fibroblasts is critically dependent on fibroblast-derived thrombospondin 1 and CD36. Am J Pathol 2003;162:771-779. (Pubitemid 36237486)
22. DiPietro LA, Nissen NN, Gamelli RL, Koch AE, Pyle JM, Polverini PJ. Thrombospondin 1 synthesis and function in wound repair. Am J Pathol 1996;148:1851-1860. (Pubitemid 26171679)
23. Barbul A. Immune aspects of wound repair. Clin Plast Surg 1990;17:433-442. (Pubitemid 20321235)
24. Diegelmann RF, Cohen IK, Kaplan AM. The role of macrophages in wound repair: a review. Plast Reconstr Surg 1981;68:107-113. (Pubitemid 11075544)
25. Leibovich SJ, Wiseman DM. Macrophages, wound repair and angiogenesis. Prog Clin Biol Res 1988;266:131-145.
26. Leibovich SJ, Ross R. The role of the macrophage in wound repair: a study with hydrocortisone and antimacrophage serum. Am J Pathol 1975;78:71-100.
27. Adamson IY, Letourneau HL, Bowden DH. Enhanced macrophage-fibroblast interactions in the pulmonary interstitium increases fibrosis after silica injection to monocyte-depleted mice. Am J Pathol 1989;134:411-418. (Pubitemid 19063897)
28. Agostini C, Siviero M, Semenzato G. Immune effector cells in idiopathic pulmonary fibrosis. Curr Opin Pulm Med 1997;3:348-355. (Pubitemid 127498380)
29. Bowden DH. The alveolar macrophage. Environ Health Perspect 1984;55:327-341. (Pubitemid 14094818)
30. Khalil N, Greenberg AH. The role of TGF-beta in pulmonary fibrosis. Ciba Found Symp 1991;157:194-207.
31. Nakamura H, Fujishima S, Waki Y, Urano T, Sayama K, Sakamaki F, Terashima T, Soejima K, Tasaka S, Ishizaka A, et al. Priming of alveolar macrophages for interleukin-8 production in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995;152:1579-1586. (Pubitemid 3002099)
32. Ali NA, Gaughan AA, Orosz CG, Baran CP, McMaken S, Wang Y, Eubank TD, Hunter M, Lichtenberger FJ, Flavahan NA, et al. Latency associated peptide has in vitro and in vivo immune effects independent of TGF-beta1. PLoS One 2008;3:e1914.
33. Baran CP, Opalek JM, McMaken S, Newland CA, O'Brien JM Jr, Hunter MG, Bringardner BD, Monick MM, Brigstock DR, Stromberg PC, et al. Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 2007;176:78-89. (Pubitemid 47048057)
34. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 1994;216:276-284. (Pubitemid 24076008)
35. Lichtenberger FJ, Montague C, Hunter M, Frambach G, Marsh CB. NAC and DTT promote TGF-beta1 monomer formation: demonstration of competitive binding. J Inflamm (Lond) 2006;3:7.
36. Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H, Hynes RO. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 1998;101:982-992. (Pubitemid 28125276)
37. Gauer S, Segitz V, Goppelt-Struebe M. Aldosterone induces CTGF in mesangial cells by activation of the glucocorticoid receptor. Nephrol Dial Transplant 2007;22:3154-3159. (Pubitemid 350202564)
38. Suzuma K, Naruse K, Suzuma I, Takahara N, Ueki K, Aiello LP, King GL. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-Akt-dependent pathways in retinal vascular cells. J Biol Chem 2000;275:40725-40731. (Pubitemid 32054890)
39. Manns JM, Uknis AB, Rico MC, Agelan A, Castaneda J, Arango I, Barbe MF, Safadi FF, Popoff SN, De La Cadena RA. A peptide from thrombospondin 1 modulates experimental erosive arthritis by regulating connective tissue growth factor. Arthritis Rheum 2006;54:2415-2422. (Pubitemid 44205001)